SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
50778If you have additional info on FGEN or pamr, I assure you I'm a good listeneArt Bechhoefer-3/8/2019
50777I thought I would respond...but....! Disclosure: Long FGEN (short Pamr,.... forMiljenko Zuanic-3/8/2019
50776Various chemo treatments used for pancreatic cancer have been able to increase tArt Bechhoefer-3/8/2019
50775< Additionally, the prospect for pamrevlumab becoming the only effective treaMiljenko Zuanic13/8/2019
50774There appears to be little institutional interest in development stage drug stocArt Bechhoefer-3/8/2019
50773This seemed a useful summary of opportunity and risks of Fibrogen to me, seekingA.J. Mullen-3/8/2019
50772Alnylam reports top-line Phase III results for Givisoran in acute hepatic porphyA.J. Mullen-3/6/2019
50771LGND: I guess the Promacta sale was not well liked? Could anyone shed any lighatticus4paws-3/6/2019
50770damn, Gottlieb resigning [X] Very impressive move in biotech on this news, actquidditch-3/5/2019
50769nvcr - Subgroup analysis data. link.springer.comsemi_infinite 13/4/2019
50768The Barrons article is a generalist one with a gene therapy focus I would say itghmm-3/4/2019
50767The BARRON'S article on GT is interesting but curiously relevant informationArt Bechhoefer-3/4/2019
50766Wow! When I responded to your initial SI message, I had no idea that you were THbmaz001-3/3/2019
50765Your quick and much appreciated! I tend to group GT into three baskets (right nghmm13/3/2019
50764Thanks for the feedback. I've added most of your suggested ticker symbols tobmaz00113/2/2019
50763Thanks for putting together another useful spreadsheet! Really appreciate it! ghmm-3/2/2019
50762Speaking of Gene Therapy, I've published a spreadsheet of GT stocks at the fbmaz00193/2/2019
50761Request - is anyone aware of a sublingual vitamin D preparation which does not inigel bates-3/2/2019
50760I checked out the Idorsia web site and, like you, found it attractive and well oArt Bechhoefer-3/1/2019
50759Art, You are correct--very little on Yahoo! Basically there isn't anything tArthur Radley-3/1/2019
50758Very little data available on IDRSF, at least not much data on Yahoo/finance. TArt Bechhoefer-3/1/2019
50757Peter, seekingalpha.com This is a link for the Seeking Alpha article--Rising SArthur Radley-3/1/2019
50756Peter-- Concerning your comment--"if you find that great long-term Asian inArthur Radley-3/1/2019
50755Wonder if Gene Therapy adoption there does well. Where there is big efficacy theghmm-3/1/2019
50754Future bios will in large part be exposed and focused on *genetic make-up* of thMiljenko Zuanic-3/1/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News